Tools
Lacunar Stroke
Introduction
Stroke is the second most common cause of death worldwide and the leading cause of disability in the United States. Ischemic strokes are the most common, comprising about 62% of strokes worldwide in 2019. The remainder are hemorrhagic. Lacunar strokes account for about 25% of all ischemic strokes. By definition, these strokes are small and located in noncortical areas. These infarcts are classically defined to be smaller than 15 mm in diameter. However, more recent studies have found that the size correlates more with the order of the penetrating branches from the parent artery. The diameter may vary from 2 to 3 mm to 15 to 20 mm.[1][2]
The name lacunar, derived from the Latin lacune, meaning pond or pit, refers to the final pathology of small subcortical spaces in the grey or white matter filled with cerebrospinal fluid. The occlusion of small, deep, penetrating branches of the cerebral vessels arising from the circle of Willis, including branches of the middle cerebral artery, anterior cerebral artery, posterior cerebral artery, or basilar artery, causes lacunar infarctions.[3] These penetrating arteries are end arteries without any collaterals. Many lacunar strokes remain asymptomatic due to the involvement of small vessels, causing small infarcts.
Additionally, 20% to 50% of the older adult population were found to have asymptomatic lacunar strokes on imaging.[4] However, accumulating multiple small lacunar infarcts can lead to significant physical and cognitive disabilities. Despite not having the devastating effects of large vessel strokes, lacunar strokes are not benign. About 25% will die from the lacunar stroke or complications, 20% will have a recurrent cerebrovascular event, and 30% will be functionally impaired at a 5-year follow-up.[5] Certain clinical syndromes are characteristic of lacunar stroke symptoms, but the correlation is not absolute. For example, large-vessel cortical strokes can present with the same clinical picture as lacunar strokes, and lacunar strokes can be caused by embolic sources or disease in large cerebral vessels, leading to occlusion of small perforating arteries, rather than the typical lipohyalinosis or thrombosis associated with lacunar strokes.[5]
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
Ischemic strokes are due to the occlusion of vascular supply to a specific part of the brain, leading to tissue hypoxia and damage. In lacunar infarction, small penetrating cerebral vessels supplying subcortical areas are occluded by various vascular pathologies, including lipohyalinosis and microatheromas.[4] In some cases, small embolic fragments from a cardiac source or large vessel disease can cause deep penetrating artery occlusion. In other cases, large-vessel disease that blocks the origin of a small perforating artery causes ischemia.[6][7][8]
The development of small vessel disease, causing a lacunar stroke, is mainly due to underlying medical conditions, eg, hypertension and diabetes mellitus. Other risk factors include smoking, LDL levels, carotid artery atherosclerosis, peripheral artery disease, previous TIA, and hyperhomocysteinemia.[4] Genetic factors also increase the risk of developing small vessel disease, leading to lacunar infarcts. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare genetic disorder that can cause small vessel arteriopathy. Caused by mutations in the NOTCH3 gene on chromosome 19, CADASIL is the most common inherited cause of stroke and dementia in adults.[9] While clinical presentations vary, the most common symptoms and signs, starting around the third or fourth decade of life, include recurrent ischemic strokes, transient ischemic attacks, progressive white matter degeneration, memory loss, migraine with aura, debilitating dementia, and multiple psychiatric symptoms.[10]
A pathognomic feature of CADASIL is granular osmophilic material found near blood vessels, which can be seen on skin biopsy under electron microscopy. The result is degeneration of blood vessels, and the disease is incurable and fatal. Characteristic magnetic resonance imaging (MRI) features are white matter hyperintensities in the anterior temporal lobes, external capsules, and superior frontal gyri.[9] Other less common genes associated with cerebral small-vessel disease include HTRA1, TREX1, GLA, COL4A1, COL4A2, FOXC1, and PITX2. The ApoE4 gene may also confer increased susceptibility to cerebral small vessel disease, in addition to being a risk factor for Alzheimer disease.[26]
Epidemiology
Lacunar stroke accounts for 20% to 30% of all ischemic strokes. In a community-based study, the incidence rate of lacunar infarct in a predominantly White community was 29 per 100,000 population, while in another community-based study with a mostly Black population, the incidence rate of lacunar infarct was 52 per 100,000 people.[11][12] The overall incidence of lacunar stroke is estimated at 25 to 50 per 100,000 people.[13] In a follow-up study, patients with lacunar infarcts are diagnosed with dementia 4 to 12 times more frequently than the average population.[14] Lacunar stroke at an older age is associated with worse long-term disability.[15]
Pathophysiology
Cerebral circulation is dependent on the internal carotid and vertebral arteries, which form the circle of Willis.[16] The main cerebral branches include the middle cerebral artery, anterior cerebral artery, posterior cerebral artery, and basilar artery, which supply the cerebrum, cerebellum, and brainstem. These arteries have deep branches that penetrate and feed the deep gray and white matter of the cerebrum, cerebellum, and brainstem.[16]
Occlusion or blockage of the small penetrating arteries, which typically have a diameter of 40 to 900 μm, causes small lacunar strokes. Their size ranges from 3 mm to 20 mm, as acute infarcts may be slightly larger than the resulting lacunes due to edema.[4] Surprisingly, a large study found that infarct size and small-vessel lesion characteristics did not affect whether a lesion was symptomatic or asymptomatic.[17] Small arterial occlusion is the fundamental pathogenesis for lacunar strokes. The primary underlying pathophysiological processes are lipohyalinosis and microatheroma formation.[18] In lipohyalinosis, the media of small vessels thickens, followed by fibrinoid deposition and hypertrophy of smooth muscle and other connective tissue elements. This results in the characteristic fibrinoid wall necrosis and segmental artery disorganization. This disorganization significantly reduces the luminal diameter of small arteries, leading to hypoperfusion of subcortical areas. They tend to be more distal towards the termination of the small penetrating arteries.[4]
Microatheromas are atheromatous arterial lesions within the brain parenchyma. They cause occlusion or stenosis of deep penetrating brain arteries. Histologically, a microatheroma is identical to a large-vessel atheroma. Microatheromas are characterized by subintimal lipid deposition and proliferation of fibroblasts, smooth muscle cells, and lipid-laden macrophages. Microatheromas are generally located in the proximal region near the origin of the parent artery in the wider part of the small arteries.[18]
More recent studies have elucidated the role of endothelial cell dysfunction and blood-brain barrier disruption. Aging, oxidative stress, underlying genetic factors, and hypertension can cause endothelial cell inflammation, leading to connective tissue replacing normal blood vessel tissue, causing luminal narrowing, thrombosis, and occlusion.[4] Other studies have shown that increased blood-brain barrier permeability is associated with increased lacunar stroke risk and poor functional outcomes.[5]
Deep penetrating branch occlusion via direct emboli or thrombus from a cardiac or large-artery source can also cause a lacunar stroke. One prospective study found that 11% of patients diagnosed with a lacunar stroke had a potential embolic source.[19] Other rare postulated reasons for small cerebral infarcts include embolism, vasculitis, infections, and vasospasm, which are not proven by autopsy. Autopsy studies are often inconclusive because they are frequently performed many years after the ischemic event, by which time the vasculature and anatomic findings may have changed. One study performed magnetic resonance imaging 1 year after minor strokes and found 37% of patients had regression of white matter hyperintensity, which could represent decreased small vessel disease. The decrease correlated with a decrease in blood pressure.[20]
Histopathology
A lacune is generally identified on autopsy as a fluid-filled cavity that marks the healed stage of small infarcted brain tissue. Histopathology describes 3 types of lacunes. Type 1 is classified as an ischemic infarct, type 2 is an old hemorrhage, and type 3 includes a dilated perivascular space.[17] In the 1960s, neurologist Charles Miller Fisher performed autopsy studies on patients and noted specific pathological changes associated with lacunar infarcts. This study showed a characteristic histopathological finding of segmental arterial disorganization, fibrinoid degeneration, segmental arteriolar disorganization, and vessel enlargement with hemorrhage.[4][21] He termed this change "lipohyalinosis"; this results in the loss of normal arterial architecture, accompanied by mural foam cells and fibrinoid necrotic changes in vessel walls.[22] The other characteristic pathological change in the small penetrating arteries causing lacunar infarcts is "microatheroma." Histologically, a microatheroma resembles a large-vessel atheromatous plaque, characterized by subintimal deposition of lipids, proliferation of fibroblasts and smooth muscle cells, and the presence of lipid-laden macrophages.[21]
History and Physical
As with ischemic strokes, lacunar infarcts usually present with a sudden onset of neurological deficits. However, a subset of lacunar infarctions may present in a stepwise pattern and worsen during admission. These are called stuttering lacunar infarcts. Lacunar infarcts are common in the subcortical deep brain structures, including the thalamus, basal ganglia, pons, and white matter of the internal capsule. Lacunar infarcts can be asymptomatic and are noted on imaging as incidental findings.
Clinical presentation depends on the area of brain involvement. Lacunar infarcts in the centrum semiovale may present without symptoms and can be found incidentally on brain imaging for some other cause. However, certain lacunar infarcts, eg, in the posterior limb of the internal capsule or the pons, can present with severe hemiplegia. Cortical findings, including neglect, visual disturbances, aphasia, and behavioral changes, are typically and uniformly absent in the clinical presentation of lacunar stroke as they occur in subcortical areas of the brain.
Lacunar strokes seldom affect memory, language, and judgment. Approximately 20 different types of lacunar syndromes have been described in the literature. The most common lacunar syndromes include:
- Pure motor hemiparesis: Pure motor hemiparesis involves the posterior limb of the internal capsule, corona radiate, or ventral pons. This type presents with contralateral hemiparesis of the face, arm, and leg. Mild dysarthria may be present with the absence of sensory symptoms. This is the most common presentation, accounting for 45% of lacunar stroke cases. Cortical signs, eg, aphasia, cognitive deficit, or visual symptoms, are always absent. Pure motor stroke can involve weakness in the arm, leg, or face on 1 side, or any of these parts alone.
- Ataxic-hemiparesis: Ataxic-hemiparesis comprises 10% to 18% of cases and involves the internal capsule, pons, or corona radiata. This type of lacunar stroke causes contralateral hemiparesis of the face and leg, with ataxia of the contralateral limb. Ataxia is the prominent feature of this stroke, in addition to milder hemiparesis.
- Pure sensory: Pure sensory stroke involves the thalamus; it presents with the impaired or abnormal sensation of the contralateral face, arm, and leg. Pure sensory stroke accounts for 7% of cases of lacunar strokes. The sensations affected are pain, temperature, touch, pressure, vision, hearing, and taste. A common form of thalamic lacunar stroke is known as poststroke thalamic pain (ie, Dejerine-Roussy syndrome). This is a syndrome of spontaneous neuropathic pain, often involving allodynia and hyperalgesia, after a thalamic lacunar infarct with pure sensory hemianesthesia.[23]
- Dysarthria-clumsy hand: This syndrome involves the pons or internal capsule. Dysarthria-clumsy hand syndrome presents with dysarthria and difficulty pronouncing words due to weakness of the voice box muscles, including the tongue, larynx, and other facial muscles. Contralateral clumsiness of the upper extremity is present with preserved motor strength. Difficulty with subtle fine movements (eg, writing or tying a shoelace) may be present.
- Sensory-motor: A sensory-motor stroke involves the thalamus, internal capsule, or putamen-capsule-caudate and presents clinically with a combination of contralateral sensory and motor loss. Sensory-motor lacunar strokes are the second most common type of lacunar stroke. They account for 20% of cases.[24][25][26]
Most penetrating branches arise from the middle cerebral artery; the intracranial non-stenotic atheroma in the large vessel may cause a lacunar stroke by blocking the penetrating branch artery at its takeoff point.[27] These infarcts are generally more extensive than the typical lacunar infarcts and are called striatocapsular infarcts. Neurological fluctuation and deterioration are common features of subcortical strokes. More than 40% with subcortical infarct deteriorate neurologically within the first week of onset of stroke symptoms. One-third of patients with deterioration reverse spontaneously. The rest suffer a physical disability.[28] Lacunar strokes are a common cause of vascular dementia and mild cognitive impairment, often overlooked in clinical practice. Multiple silent lacunar strokes are documented on brain magnetic resonance imaging, with patients presenting with mild cognitive impairment and early dementia.[29]
Evaluation
The STRIVE criteria (Standards for Reporting Vascular Changes on Neuroimaging) are a consensus guideline for cerebral small-vessel disease, using criteria, eg, recent small subcortical infarcts, white matter hyperintensities, perivascular spaces, microbleeds, and brain atrophy, based on imaging studies for disease classification.[30]
Transcranial Doppler
This safe, noninvasive study can provide important information on structural, functional, and hemodynamic characteristics, including blood flow velocity and the pulsatility index of cerebral blood vessels. A higher pulsatility index is associated with increased vascular resistance, greater small-vessel disease, and larger acute infarct size. Pulsatility index was directly associated with infarct volume.[31] Transcranial Dopplers can also assess cerebral autoregulation, which is usually decreased in a stroke setting.[26]
Computed Tomography
The sudden onset of a neurological deficit requires emergent neuroimaging. An initial noncontrast head computed tomography (CT) scan is preferred in an acute setting, as this modality is readily available, quick, and valuable for ruling out life-threatening conditions (eg, intracerebral bleeding or herniation) and to clear the patient for possible intervention. CT scans seldom detect lacunar ischemic infarcts within the first 24 hours because of their small size. If seen, lacunar strokes present as ill-defined hypodensities unless a hemorrhagic component to the acute stroke is present. A hyperdensity in a large artery on a noncontrast head CT indicates the presence of a thrombus inside the arterial lumen or vessel calcification. Early infarct signs on noncontrast CT include loss of gray-white differentiation and focal hypoattenuation of brain parenchyma. These details are difficult to read in small subcortical strokes. Chronic lesions may appear as hypodense foci.[4]
A CT angiogram of the head and neck can also be performed. This may show a filling defect consistent with a thrombus blocking a specified vessel. A CT angiogram may also show arterial narrowing and extensive chronic vascular disease, eg, in the carotid arteries, which may be a source of an embolus, or it may show middle cerebral artery features consistent with an atheroma. Neurovascular imaging modalities are essential to locate the presence of large artery occlusion as they help determine the need for catheter-guided thrombolysis. In general, large-vessel strokes are more likely to benefit from thrombectomy than lacunar infarcts.[4] CT perfusion studies can also demonstrate an infarct core, indicating irreversible ischemia, and a penumbra, indicating reversible ischemia. This modality can also be used to evaluate patients for possible thrombectomy, as lacunar strokes are usually not appropriate for thrombectomy.[32]
Magnetic Resonance Imaging
MRI is a superior imaging modality for detecting lacunar infarctions in acute and subacute settings. In the acute stage, the MRI diffusion-weighted image (DWI) has the highest sensitivity, as this modality will be positive within half an hour of stroke onset and will remain positive for about 7 days. MRI-DWI helps to differentiate between acute and chronic infarctions.[33] In an acute setting, on T1-weighted images, lacunes appear as focal areas of decreased signal intensity, and on T2-weighted images as focal areas of hyperintensity. Chronic lesions are isointense to cerebral spinal fluid on all sequences. MRI can detect lesions as small as 0.2 mm, which a CT scan cannot detect. Recent advances in high-resolution MRI can also image cerebral perforating arteries for the first time, as well as their velocity and pulsatility index.[33][34]
Additional Diagnostic Studies
A carotid ultrasound can help diagnose an atherosclerotic narrowing of the extracranial carotid artery when a neck angiogram is not performed. The risk of stroke is higher in patients with severe carotid artery stenosis. Depending on clinical symptoms, significant stenosis can range from 50% to 99%. See StatPearls' companion article "Carotid Stenosis" for further information on carotid imaging.[35] Extensive embolic workup, including echocardiography and vascular imaging, has a very low yield in cases of lacunar stroke.[36] However, this may be necessary in some cases, like in young patients with no apparent medical issues.
Other immediate tests to be performed include blood glucose levels, electrocardiogram, complete blood count including platelets, troponin, prothrombin time, international normalized ratio (INR), activated partial thromboplastin time, complete metabolic panel, lipid panel, hemoglobin A1c, and toxicology screen. These tests are helpful in the assessment of underlying stroke risk factors.
Treatment / Management
Lacunar Stroke Management
Treatment principles for acute lacunar stroke are similar to those for any acute ischemic stroke. The initial goal of acute-stage treatment is to ensure medical stability and determine candidacy for thrombolysis. Intravenous thrombolysis is the mainstay of medical management. Tissue plasminogen activator (tPA) improves outcomes for patients with ischemic stroke if administered within 4.5 hours of symptom onset. Once intracerebral bleeding is ruled out, intravenous thrombolysis is an important step in acute treatment.[34][37][38] Tenecteplase is now the preferred thrombolytic agent based on multiple phase 3 trials demonstrating noninferiority to alteplase with easier single-bolus administration. The 2026 AHA/ASA guidelines support tenecteplase as the thrombolytic of choice.[39] Altepease remains an alternative, given as 10% bolus followed by a 60-minute infusion. For a patient with salvageable ischemic penumbra detected on CT/MRI perfusion imaging and who awakens with stroke symptoms within 9 hours of the midpoint of sleep, IV thrombolysis is reasonable to improve functional outcome per the 2026 Stroke guidelines. Delay antiplatelet therapy for 24 hours postintravenous thrombolysis, and should be initiated after neuroimaging confirms no intracranial hemorrhage.[40](B2)
Thrombectomy was previously restricted to patients presenting within 6 hours of neurologic deficit onset. However, more recent trials, including the DAWN (DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo) and DEFUSE 3 (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke) trials, showed benefit when the treatment window was extended to 16 to 24 hours.[32][41] An extended window requires advanced imaging, eg, a CT or MRI perfusion scan. If symptom onset duration is greater than 4.5 hours and suspicion of an intracranial arterial occlusion in the anterior circulation is present, CT angiography and magnetic resonance angiography are useful for selecting candidates for mechanical thrombectomy between 6 and 24 hours from when they were last known to be unaffected. (B3)
Management of a patient who presents with an acute lacunar infarct out of the tPA window, consistent with a noncardioembolic stroke, includes dual antiplatelet therapy with aspirin and clopidogrel within 24 hours of symptom onset and continued for 21 days. Dual antiplatelet therapy in the acute phase effectively lowers the risk of recurrent ischemic stroke for 90 days from symptom onset. This is supported by the Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) and the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials. These studies were performed on patients with all types of ischemic stroke, but supported for use in lacunar strokes in subgroup analysis. Antiplatelet therapy should be delayed for 24 hours in patients who received tPA.[34] Patients with stuttering lacunar infarcts may also benefit from intravenous tPA. Heparin has been studied in acute lacunar stroke and was found to confer no benefit but increase the bleeding risk.
The goal blood pressure before administering tPA is less than 185/110 mm Hg; after administering, the goal is less than 180/105 mm Hg.[42] Management of hypertension includes allowing for permissive hypertension and cerebral autoregulation unless the blood pressure is markedly elevated to greater than 220/120 mm Hg; in this case, blood pressure should be lowered by 15% during the first 24 hours, and outpatient antihypertensive medications should be held unless other comorbid conditions require the immediate lowering of blood pressure.[34]
Blood sugar management is performed to maintain euglycemia, with a target blood glucose range of 140 to 180 mg/dL. Both hypoglycemia and hyperglycemia should be monitored and corrected. The recommended hemoglobin A1c goal is 6.5% to 7%. The Insulin Resistance Intervention after Stroke Trial (IRIS) followed 3,000 patients with insulin-resistant diabetes who were treated with pioglitazone. After 5 years, patients in the treatment group had lower blood sugars, as well as decreased rates of stroke and myocardial infarction compared to placebo.[34] The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study investigated the use of high-dose statins to prevent stroke recurrence. Over 4,000 patients with a recent transient ischemic attack or stroke but without known coronary artery disease were randomized to high-dose atorvastatin or placebo. The risk of stroke or cardiovascular event was significantly decreased in the statin group, but was associated with a slight increase in intracranial hemorrhage.[43] (A1)
Stroke Prevention
Primary and secondary stroke prevention remains an essential part of the treatment plan. Primary prevention includes the prevention of the first episode of stroke, and secondary prevention consists of the prevention of recurrence. Primary stroke prevention measures include risk factor management that uses antihypertensive medications, diabetes control, cholesterol-lowering agents, smoking cessation, dietary intervention, weight loss, and exercise.
Secondary prevention comprises antithrombotic agents (eg, aspirin, clopidogrel, extended-release dipyridamole, and ticlopidine) and management of underlying risk factors. Antiplatelet agents reduce the risk of recurrence in patients with lacunar strokes.[44] Blood pressure reduction to a systolic target of less than 130 mm Hg is beneficial.[45] Diabetes control (HbA1c <7%), lipid management (LDL <70mg/dL), smoking cessation, weight loss, and regular exercise are included in secondary prevention strategies. Dual antiplatelet therapy with aspirin (50-100 mg) plus clopidogrel (75 mg) for 21 to 30 days after a minor stroke, followed by lifelong antiplatelet monotherapy, is recommended. For lacunar stroke, no evidence has demonstrated that clopidogrel is superior to aspirin for secondary stroke prevention. (A1)
The Secondary Study of Small Subcortical Strokes included over 3,000 patients with lacunar strokes, as demonstrated by MRI. This study evaluated blood pressure goals and found that a systolic blood pressure goal of less than 130 mm Hg significantly reduced the incidence of hemorrhagic stroke.[45] This study also evaluated the use of clopidogrel plus aspirin versus aspirin alone in the same population. Findings were that adding clopidogrel to aspirin alone did not reduce recurrent stroke risk but did increase the risk of death and significant bleeding.[46][46] Recent 2023 subset analysis suggests lacunar strokes may benefit more from DAPT, though this was only a 90-day study [47] (A1)
Secondary stroke prevention is an essential strategy, preventing as many as 80% of all recurrent strokes.[48] Oral anticoagulants are not considered for small cerebral vessel disease-related stroke prevention, including recurrent lacunar infarcts, as they disproportionately increase the risk of intracranial cerebral hemorrhage.[49] Physical therapy and rehabilitation are essential steps for managing patients with lacunar strokes that cause physical disability. These patients require rehabilitation. The goal of rehabilitation is to optimize functional recovery after a stroke, increase independence, and maintain quality of life.
Differential Diagnosis
Many physiologic states mimic the presentation of stroke. The differential diagnoses of lacunar infarcts include the following:
- Large vessel ischemic stroke in the middle cerebral artery territory is clinically differentiated from lacunar strokes by the presence of cortical signs, including altered mental status, aphasia, and hemineglect.
- Intracranial hemorrhages can usually be seen on neuroimaging modalities like brain CT scans.
- Seizures are caused by excess neuronal activity and can be differentiated clinically by their tonic-clonic activity, resolution of symptoms postseizure, and postictal state.
- Complicated migraine symptoms are usually accompanied by headache and aura. A typical aura may involve visual disturbances, sensory symptoms, motor weakness, or speech disturbances.
- Brain tumors are distinguished by their characteristic appearance on MRI.
- Multiple sclerosis can cause paroxysmal attacks of ataxia and dysarthria. MRI helps distinguish the presence of plaques due to multiple sclerosis from a stroke. Further, cerebral vasoreactivity measured by transcranial Doppler (TCD) sonography can be used to differentiate ischemic and demyelinating lesions. The presence of oligoclonal bands on lumbar puncture is characteristic of multiple sclerosis.
- Hypoglycemia can mimic stroke symptoms with decreased consciousness and even focal deficits. A blood sugar fingerstick should always be checked upon presentation.
- Transient global amnesia can present with selective amnesia without focal neurologic deficits. Symptoms usually resolve within 24 hours and are not associated with imaging abnormalities. Please see our companion StatPearls article, "Transient Global Amnesia, " for further information.[50]
Prognosis
Earlier studies suggested that lacunar stroke has a better immediate prognosis compared to other strokes. A recent review of the literature shows that lacunar stroke has a paradoxical prognosis. The short-term prognosis of lacunar stroke is a high survival rate, a low recurrence rate, and a relatively good functional recovery. In general, lacunar infarcts have a relatively favorable prognosis.[51] Long-term prognosis (beyond 1 year )with lacunar stroke constitutes an increased risk of death, mainly from cardiovascular causes. Dementia is seen in 9% to 12% of patients by 9 years.[52] The risk of stroke recurrence is similar to that of any other type of stroke.[53]
Complications
Lacunar strokes are thought to be the leading cause of vascular dementia and cognitive impairment.[54] Accumulated lacunar infarcts can lead to other disease-related complications due to physical disability, including, but not limited to, aspiration pneumonia, deep vein thrombosis, pulmonary embolism, urinary tract infection, depression, and decubitus ulcers.
Postoperative and Rehabilitation Care
Most patients with lacunar infarctions have significant improvements in neurologic deficits. Physical therapy, speech therapy, occupational therapy, and rehabilitation services remain essential after hospital care to regain maximum strength and functional level after a stroke.
Consultations
A team approach in a stroke center best manages acute stroke patients. Early consultation with physical therapists, occupational therapists, and physical medicine and rehabilitation physicians will improve outcomes for stroke patients.[55]
Deterrence and Patient Education
Patients should be educated about risk factors that increase the risk of stroke. Compliance with antithrombotic agents to prevent stroke recurrence is essential. Patients are advised to maintain a healthy diet, exercise regularly, avoid smoking, and avoid excessive alcohol use. Together, these habits reduce the risk of having strokes in general. If patients have high blood pressure, lipid disorder, or diabetes, regular follow-up with their primary care clinician is essential to keep these risk factors optimally controlled.
The timeline of recovery from a lacunar stroke is different for everyone. Home safety is essential. Becoming a fall risk due to physical disability is common. Depression is common in people who have experienced a stroke and should be addressed if present. Cognitive impairment due to multiple subcortical strokes can progress to vascular dementia and should be monitored.
Enhancing Healthcare Team Outcomes
Lacunar stroke is a common subtype of ischemic stroke caused by occlusion of small penetrating cerebral arteries, leading to small subcortical infarcts associated with significant long-term morbidity. Despite often subtle or stereotyped presentations such as pure motor or sensory deficits, these strokes carry substantial risks of recurrence, functional impairment, and vascular dementia. Pathophysiology commonly involves lipohyalinosis and microatheroma formation driven by hypertension, diabetes, and other vascular risk factors. Early evaluation relies on prompt neuroimaging, with MRI diffusion-weighted imaging offering high sensitivity. Management includes timely consideration of thrombolysis, short-term dual antiplatelet therapy when appropriate, and aggressive risk factor modification, including blood pressure, lipid, and glycemic control, to reduce the risk of recurrence and complications. The care of patients with lacunar strokes necessitates a collaborative approach among healthcare professionals to ensure patient-centered care and improve overall outcomes. Neurologists, emergency medicine physicians, critical care physicians, advanced practitioners, nurses, pharmacists, and other health professionals involved in the care of these patients should possess the essential clinical skills and knowledge to diagnose and manage this condition
Interprofessional collaboration is essential to optimize outcomes and ensure patient-centered care. Physicians and advanced practitioners lead diagnosis, acute management, and guideline-directed therapy, while nurses provide continuous monitoring, patient education, and early detection of neurologic changes. Pharmacists support safe medication selection, adherence, and risk reduction strategies. Primary care clinicians coordinate long-term management and prevention, ensuring continuity of care. Rehabilitation specialists, including physical, occupational, and speech therapists, facilitate functional recovery and independence. Emphasis on managing stroke risk factors includes intense antihypertensive therapy, lipid management, and strict control of blood sugars after the lacunar ischemic event. Ethical considerations must guide decision-making, ensuring informed consent and respecting patient autonomy in treatment choices. Effective communication, shared decision-making, timely referrals, and coordinated follow-up enhance safety, minimize complications, and improve quality of care across the continuum.
References
Yang L, Qin W, Zhang X, Li Y, Gu H, Hu W. Infarct Size May Distinguish the Pathogenesis of Lacunar Infarction of the Middle Cerebral Artery Territory. Medical science monitor : international medical journal of experimental and clinical research. 2016 Jan 20:22():211-8 [PubMed PMID: 26788612]
Level 2 (mid-level) evidenceRutten-Jacobs LCA, Markus HS, UK Young Lacunar Stroke DNA Study. Vascular Risk Factor Profiles Differ Between Magnetic Resonance Imaging-Defined Subtypes of Younger-Onset Lacunar Stroke. Stroke. 2017 Sep:48(9):2405-2411. doi: 10.1161/STROKEAHA.117.017813. Epub 2017 Aug 1 [PubMed PMID: 28765289]
Dickmann E, Müller E. [Lacunar cerebral infarcts]. Zeitschrift fur Gerontologie. 1985 Jul-Aug:18(4):222-5 [PubMed PMID: 4050007]
Regenhardt RW, Das AS, Lo EH, Caplan LR. Advances in Understanding the Pathophysiology of Lacunar Stroke: A Review. JAMA neurology. 2018 Oct 1:75(10):1273-1281. doi: 10.1001/jamaneurol.2018.1073. Epub [PubMed PMID: 30167649]
Level 3 (low-level) evidenceRudilosso S, Rodríguez-Vázquez A, Urra X, Arboix A. The Potential Impact of Neuroimaging and Translational Research on the Clinical Management of Lacunar Stroke. International journal of molecular sciences. 2022 Jan 28:23(3):. doi: 10.3390/ijms23031497. Epub 2022 Jan 28 [PubMed PMID: 35163423]
Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Current cardiology reviews. 2010 Aug:6(3):150-61. doi: 10.2174/157340310791658730. Epub [PubMed PMID: 21804774]
Palacio S, McClure LA, Benavente OR, Bazan C 3rd, Pergola P, Hart RG. Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study. Stroke. 2014 Sep:45(9):2689-94. doi: 10.1161/STROKEAHA.114.005018. Epub 2014 Jul 17 [PubMed PMID: 25034716]
Level 1 (high-level) evidenceBell DSH, Goncalves E. Stroke in the patient with diabetes (part 1) - Epidemiology, etiology, therapy and prognosis. Diabetes research and clinical practice. 2020 Jun:164():108193. doi: 10.1016/j.diabres.2020.108193. Epub 2020 May 20 [PubMed PMID: 32442554]
Ferrante EA, Cudrici CD, Boehm M. CADASIL: new advances in basic science and clinical perspectives. Current opinion in hematology. 2019 May:26(3):193-198. doi: 10.1097/MOH.0000000000000497. Epub [PubMed PMID: 30855338]
Level 3 (low-level) evidenceManini A, Pantoni L. CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches. Molecular neurobiology. 2021 Jun:58(6):2558-2573. doi: 10.1007/s12035-021-02282-4. Epub 2021 Jan 19 [PubMed PMID: 33464533]
Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999 Dec:30(12):2513-6 [PubMed PMID: 10582970]
Woo D, Gebel J, Miller R, Kothari R, Brott T, Khoury J, Salisbury S, Shukla R, Pancioli A, Jauch E, Broderick J. Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study. Stroke. 1999 Dec:30(12):2517-22 [PubMed PMID: 10582971]
Level 2 (mid-level) evidenceHan S, Sun D, Jiang B, Sun H, Ru X, Jin A, Wang Y, Wang W. Prevalence and distribution of lacunar stroke in China: a cross-sectional study using self-reported survey data. BMJ open. 2022 Dec 30:12(12):e063520. doi: 10.1136/bmjopen-2022-063520. Epub 2022 Dec 30 [PubMed PMID: 36585136]
Level 2 (mid-level) evidenceLoeb C, Gandolfo C, Croce R, Conti M. Dementia associated with lacunar infarction. Stroke. 1992 Sep:23(9):1225-9 [PubMed PMID: 1519275]
Level 3 (low-level) evidenceDhamoon MS, McClure LA, White CL, Lakshminarayan K, Benavente OR, Elkind MS, SPS3 Investigators. Long-term disability after lacunar stroke: secondary prevention of small subcortical strokes. Neurology. 2015 Mar 10:84(10):1002-8. doi: 10.1212/WNL.0000000000001331. Epub 2015 Feb 6 [PubMed PMID: 25663222]
Rosner J, Reddy V, Lui F. Neuroanatomy, Circle of Willis. StatPearls. 2026 Jan:(): [PubMed PMID: 30521282]
Bailey EL, Smith C, Sudlow CL, Wardlaw JM. Pathology of lacunar ischemic stroke in humans--a systematic review. Brain pathology (Zurich, Switzerland). 2012 Sep:22(5):583-91. doi: 10.1111/j.1750-3639.2012.00575.x. Epub 2012 Mar 16 [PubMed PMID: 22329603]
Level 1 (high-level) evidenceCaplan LR. Lacunar infarction and small vessel disease: pathology and pathophysiology. Journal of stroke. 2015 Jan:17(1):2-6. doi: 10.5853/jos.2015.17.1.2. Epub 2015 Jan 30 [PubMed PMID: 25692102]
Del Bene A, Makin SD, Doubal FN, Inzitari D, Wardlaw JM. Variation in risk factors for recent small subcortical infarcts with infarct size, shape, and location. Stroke. 2013 Nov:44(11):3000-6. doi: 10.1161/STROKEAHA.113.002227. Epub 2013 Sep 5 [PubMed PMID: 24008573]
Wardlaw JM, Chappell FM, Valdés Hernández MDC, Makin SDJ, Staals J, Shuler K, Thrippleton MJ, Armitage PA, Muñoz-Maniega S, Heye AK, Sakka E, Dennis MS. White matter hyperintensity reduction and outcomes after minor stroke. Neurology. 2017 Sep 5:89(10):1003-1010. doi: 10.1212/WNL.0000000000004328. Epub 2017 Aug 9 [PubMed PMID: 28794252]
Regenhardt RW, Das AS, Ohtomo R, Lo EH, Ayata C, Gurol ME. Pathophysiology of Lacunar Stroke: History's Mysteries and Modern Interpretations. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2019 Aug:28(8):2079-2097. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.006. Epub 2019 May 28 [PubMed PMID: 31151839]
Fisher CM. The arterial lesions underlying lacunes. Acta neuropathologica. 1968 Dec 18:12(1):1-15 [PubMed PMID: 5708546]
Ri S. The Management of Poststroke Thalamic Pain: Update in Clinical Practice. Diagnostics (Basel, Switzerland). 2022 Jun 10:12(6):. doi: 10.3390/diagnostics12061439. Epub 2022 Jun 10 [PubMed PMID: 35741249]
Toni D, Del Duca R, Fiorelli M, Sacchetti ML, Bastianello S, Giubilei F, Martinazzo C, Argentino C. Pure motor hemiparesis and sensorimotor stroke. Accuracy of very early clinical diagnosis of lacunar strokes. Stroke. 1994 Jan:25(1):92-6 [PubMed PMID: 8266389]
Venkataraman P, Tadi P, Lui F. Lacunar Syndromes (Archived). StatPearls. 2026 Jan:(): [PubMed PMID: 30480945]
Chamorro A, Sacco RL, Mohr JP, Foulkes MA, Kase CS, Tatemichi TK, Wolf PA, Price TR, Hier DB. Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke. 1991 Feb:22(2):175-81 [PubMed PMID: 2003281]
Xu WH. Large artery: an important target for cerebral small vessel diseases. Annals of translational medicine. 2014 Aug:2(8):78. doi: 10.3978/j.issn.2305-5839.2014.08.10. Epub [PubMed PMID: 25333053]
Vahidy FS, Hicks WJ 2nd, Acosta I, Hallevi H, Peng H, Pandurengan R, Gonzales NR, Barreto AD, Martin-Schild S, Wu TC, Rahbar MH, Bambhroliya AB, Grotta JC, Savitz SI. Neurofluctuation in patients with subcortical ischemic stroke. Neurology. 2014 Jul 29:83(5):398-405. doi: 10.1212/WNL.0000000000000643. Epub 2014 Jun 25 [PubMed PMID: 24966405]
Level 2 (mid-level) evidenceJacova C, Pearce LA, Costello R, McClure LA, Holliday SL, Hart RG, Benavente OR. Cognitive impairment in lacunar strokes: the SPS3 trial. Annals of neurology. 2012 Sep:72(3):351-62. doi: 10.1002/ana.23733. Epub [PubMed PMID: 23034910]
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet. Neurology. 2013 Aug:12(8):822-38. doi: 10.1016/S1474-4422(13)70124-8. Epub [PubMed PMID: 23867200]
Kim Y, Lee H, An SA, Yim B, Kim J, Kim OJ, Kim WC, Kim HS, Oh SH, Kim J. The Effect of Pulsatility Index on Infarct Volume in Acute Lacunar Stroke. Yonsei medical journal. 2016 Jul:57(4):950-5. doi: 10.3349/ymj.2016.57.4.950. Epub [PubMed PMID: 27189290]
Hasan TF, Hasan H, Kelley RE. Overview of Acute Ischemic Stroke Evaluation and Management. Biomedicines. 2021 Oct 16:9(10):. doi: 10.3390/biomedicines9101486. Epub 2021 Oct 16 [PubMed PMID: 34680603]
Level 3 (low-level) evidenceNorrving B. Evolving Concept of Small Vessel Disease through Advanced Brain Imaging. Journal of stroke. 2015 May:17(2):94-100. doi: 10.5853/jos.2015.17.2.94. Epub 2015 May 29 [PubMed PMID: 26060796]
Das AS, Regenhardt RW, Feske SK, Gurol ME. Treatment Approaches to Lacunar Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2019 Aug:28(8):2055-2078. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.004. Epub 2019 May 28 [PubMed PMID: 31151838]
DaCosta M, Tadi P, Surowiec SM. Carotid Endarterectomy. StatPearls. 2026 Jan:(): [PubMed PMID: 29261917]
Wang Y, Choi Y, Gallardo J, Nwaneri I, Brorson JR. Low Yield of Extensive Workup for Embolic Sources in Lacunar Stroke Patients. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2018 Jun:27(6):1575-1581. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.009. Epub 2018 Feb 6 [PubMed PMID: 29426678]
Zivanovic Z, Gubi M, Vlahovic D, Milicevic M, Jovicevic M, Lucic A, Ruzicka-Kaloci S, Radovanovic B, Zikic TR, Zarkov M, Popovic N, Slankamenac P. Patients with Acute Lacunar Infarction Have Benefit from Intravenous Thrombolysis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2019 Feb:28(2):435-440. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.020. Epub 2018 Nov 6 [PubMed PMID: 30409747]
Shobha N, Fang J, Hill MD. Do lacunar strokes benefit from thrombolysis? Evidence from the Registry of the Canadian Stroke Network. International journal of stroke : official journal of the International Stroke Society. 2013 Oct:8 Suppl A100():45-9. doi: 10.1111/j.1747-4949.2012.00932.x. Epub 2012 Dec 11 [PubMed PMID: 23231478]
Level 2 (mid-level) evidencePrabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, Menon B, Mistry EA, Park S, Parker S, Pérez de la Ossa N, Reeves M, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S, Peer Review Committee. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2026 Jan 26:():. doi: 10.1161/STR.0000000000000513. Epub 2026 Jan 26 [PubMed PMID: 41582814]
Greco A, Occhipinti G, Giacoppo D, Agnello F, Laudani C, Spagnolo M, Mauro MS, Rochira C, Finocchiaro S, Mazzone PM, Faro DC, Landolina D, Ammirabile N, Imbesi A, Raffo C, Capodanno D. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2023 Oct 10:82(15):1538-1557. doi: 10.1016/j.jacc.2023.07.025. Epub [PubMed PMID: 37793752]
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG, DAWN Trial Investigators. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. The New England journal of medicine. 2018 Jan 4:378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11 [PubMed PMID: 29129157]
Gorelick PB, Qureshi S, Farooq MU. Management of blood pressure in stroke. International Journal of Cardiology. Hypertension. 2019 Nov:3():100021. doi: 10.1016/j.ijchy.2019.100021. Epub 2019 Oct 13 [PubMed PMID: 33447751]
Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. The New England journal of medicine. 2006 Aug 10:355(6):549-59 [PubMed PMID: 16899775]
Level 1 (high-level) evidenceKong T, Chen J, Sun K, Zhang W, Wang J, Song L, Wang D, Hui R. Aspirin reduced recurrent stroke risk in patients with lacunar stroke. Acta neurologica Scandinavica. 2019 Jul:140(1):78-83. doi: 10.1111/ane.13105. Epub 2019 May 9 [PubMed PMID: 31002173]
SPS3 Study Group, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, Pergola PE, Szychowski JM. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet (London, England). 2013 Aug 10:382(9891):507-15. doi: 10.1016/S0140-6736(13)60852-1. Epub 2013 May 29 [PubMed PMID: 23726159]
Level 1 (high-level) evidenceSPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. The New England journal of medicine. 2012 Aug 30:367(9):817-25. doi: 10.1056/NEJMoa1204133. Epub [PubMed PMID: 22931315]
Level 1 (high-level) evidenceFord B, Dore MM, Koehn TR. Recurrent Ischemic Stroke: Prevention Strategies. American family physician. 2026 Jan:113(1):57-69 [PubMed PMID: 41544282]
Prabhakaran S, Chong JY. Risk factor management for stroke prevention. Continuum (Minneapolis, Minn.). 2014 Apr:20(2 Cerebrovascular Disease):296-308. doi: 10.1212/01.CON.0000446102.82420.64. Epub [PubMed PMID: 24699482]
Tsai HH, Kim JS, Jouvent E, Gurol ME. Updates on Prevention of Hemorrhagic and Lacunar Strokes. Journal of stroke. 2018 May:20(2):167-179. doi: 10.5853/jos.2018.00787. Epub 2018 May 31 [PubMed PMID: 29886717]
Nehring SM, Spurling BC, Kumar A. Transient Global Amnesia. StatPearls. 2026 Jan:(): [PubMed PMID: 28723030]
Clavier I, Hommel M, Besson G, Noèlle B, Perret JE. Long-term prognosis of symptomatic lacunar infarcts. A hospital-based study. Stroke. 1994 Oct:25(10):2005-9 [PubMed PMID: 8091445]
Jaime Garcia D, Makin SDJ, McHutchison CA, Cvoro V, Valdés Hernández MDC, Sakka E, Chappell FM, Doubal F, Wardlaw JM. Functional, Cognitive, Physical, and Vascular Outcomes 9 Years After Lacunar and Mild Cortical Ischemic Stroke. Neurology. 2025 Sep 9:105(5):e214018. doi: 10.1212/WNL.0000000000214018. Epub 2025 Aug 20 [PubMed PMID: 40834341]
Norrving B. Long-term prognosis after lacunar infarction. The Lancet. Neurology. 2003 Apr:2(4):238-45 [PubMed PMID: 12849212]
Makin SD, Turpin S, Dennis MS, Wardlaw JM. Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. Journal of neurology, neurosurgery, and psychiatry. 2013 Aug:84(8):893-900. doi: 10.1136/jnnp-2012-303645. Epub 2013 Mar 1 [PubMed PMID: 23457225]
Level 1 (high-level) evidenceShen Y, Chao BH, Cao L, Tu WJ, Wang LD. Stroke Center Care and Outcome: Results from the CSPPC Stroke Program. Translational stroke research. 2020 Jun:11(3):377-386. doi: 10.1007/s12975-019-00727-6. Epub 2019 Sep 8 [PubMed PMID: 31494833]